Is there a subtype of developmental Parkinson's disease?

scientific article

Is there a subtype of developmental Parkinson's disease? is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1007/BF03033370
P698PubMed publication ID12832222

P2093author name stringRiederer P
P2860cites workIron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processesQ22337213
Variations of monoamines and their metabolites in the human brain putamenQ28320800
Association between early-onset Parkinson's disease and mutations in the parkin geneQ29615733
Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesisQ33631298
Dopamine systems in human immunodeficiency virus-associated dementia.Q33717302
Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female ratQ34284323
Neurotransmission in HIV associated dementia: a short reviewQ34322558
Changes of D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresisQ36721399
The genetics of Parkinson's disease: a reconsiderationQ37967210
Biochemical changes in rat brain associated with the development of the blood-brain barrierQ39068612
The effect of hypoxia on brain neurotransmitter systemsQ39290876
Neurotransmitters in the regulation of neuronal cytoarchitectureQ39468488
Adrenomedullary catecholamine release in the fetus and newborn: secretory mechanisms and their role in stress and survivalQ39634161
Energy metabolism in the developing mammalian brain.Q40495266
Development of enzymes of energy metabolism in the neonatal mammalian brain.Q40559762
Pathogenesis of HIV-1 associated neurodegenerationQ41149440
Effects of prenatal stress on vulnerability to stress in prepubertal and adult ratsQ41475848
Synaptic density in human frontal cortex — Developmental changes and effects of agingQ41485344
HIV dementia and the basal gangliaQ41693843
Apoptosis in the basal ganglia of the developing human nervous systemQ42501696
Parkinsonism with HIV infectionQ42540689
Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS.Q42555161
Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugsQ43555222
The AIDS dementia complex: I. Clinical featuresQ43769670
Effects of estradiol on the ontogenesis of striatal dopamine D1 and D2 receptor sites in male and female ratsQ43912284
Follow-up study of early-life protective and risk factors in Parkinson's diseaseQ44410466
The first breaths of air stimulate noradrenaline turnover in the brain of the newborn ratQ44779086
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlationsQ45302799
Comparative studies of viral infections of the developing forebrain. I. Pathogenesis of rat virus and bluetongue vaccine virus infections in neonatal hamstersQ45818074
Vulnerability of the nigrostriatal system as detected by transcranial ultrasoundQ48106731
Prenatal stress increases anxiety related behavior and alters cerebral lateralization of dopamine activityQ48132850
The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twinsQ48216713
Human brain dopamine receptors in children and aging adultsQ48236020
AIDS: calcification of the basal ganglia in infants and childrenQ48303691
The AIDS dementia complex: II. NeuropathologyQ48340087
Late development of intrinsic excitation in the rat neostriatum: an in vitro studyQ48340425
Prenatal stress impairs maternal behavior in a conflict situation and reduces hippocampal benzodiazepine receptorsQ48480222
Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatmentQ48548598
Tyrosine hydroxylase in rat brain: developmental characteristicsQ48785814
Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineQ48881880
Postnatal development of adrenergic terminals in rat locus coeruleus, with special reference to growth of noradrenergic neuronsQ48887813
The substantia nigra is also involved in Japanese encephalitisQ49162606
Brain damage in the monkey, macaca mulatta, by asphyxia neonatorum.Q51315133
Developmental cell death in dopaminergic neurons of the substantia nigra of mice.Q52166629
Neurotransmission and the ontogeny of human brain.Q52203203
The effects of prenatal exposure to predictable or unpredictable stress on early development in the rat.Q52271811
Essential tremor in childhood: a series of nineteen cases.Q55035574
Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's diseaseQ67488394
Parkinson's disease, personality, and dopamineQ68406620
[Current status of conservative therapy of extrapyramidal movement disorders in childhood and adolescence]Q69839072
Serum vitamin A concentration is elevated in idiopathic intracranial hypertensionQ73016971
Neuronal damage of the substantia nigra in HIV-1 infected brainsQ73727349
Prenatal stress depresses immune function in ratsQ74197188
Neuropathology and general autopsy findings in AIDS during the last 15 yearsQ74237358
P433issue1-2
P304page(s)27-34
P577publication date2003-01-01
P1433published inNeurotoxicity ResearchQ15764278
P1476titleIs there a subtype of developmental Parkinson's disease?
P478volume5